Scientists at UT Southwestern have identified the protein GADD45G as a master regulator of reactive gliosis, a damaging process in neurodegenerative diseases like Parkinson's and Alzheimer’s, offering a potential new therapeutic target.
Three centers are involved in the recruiting and onboarding for a clinical study aimed at leveraging Real-World Data to enhance Parkinson's disease treatment.
An ultrasound treatment showed promise in improving the physical symptoms of Parkinson’s disease in a clinical trial.
People with weight changes soon after being diagnosed with Parkinson’s disease may be more likely to have changes in their thinking skills than people who maintain their weight, according to a recent study.
Read More
Cala TAPS therapy reduces essential tremor with no loss of effect over time and improves patient quality of life, a new study suggests.
Read More
The Muscular Dystrophy Association announces the awarding of 70 new grants totaling over $17 million toward neuromuscular disease research.
Read More
Flexible implantable electronics are a step closer toward clinical applications thanks to a recent breakthrough technology.
Read More
Patients with essential tremor and Parkinson’s disease have a higher prevalence of comorbidities, according to new research from Cala Health.
Read More
Focused ultrasound offers treatment for people suffering from essential tremor, Parkinson’s disease, and other neurological disorders.
Read More
Older people taking statins have a lower chance of developing parkinsonism later compared to people who weren’t taking statins, per research.
Read More
JOGO-Gx, a digital therapeutic that taps into the neuroplasticity of the brain using biofeedback, shows early success as a Parkinson’s treatment.
Read More
New coding and coverage by commercial and government payors makes it easier for physicians to prescribe and patients to afford Cala Health’s clinically proven treatment for essential tremor, Cala Trio therapy, the company notes in a media release.
Read More
A common gene mutation for Parkinson’s disease drives mislocalization of iron in activated microglia, according to a study published recently in PLOS Biology, by Mark Cookson of the National Institute on Aging and colleagues.
Read More
Transcranial direct current stimulation (tDCS) can increase the benefits of aerobic exercise and improve the gait of patients with Parkinson’s disease immediately after a session, researchers suggest, in Neurorehabilitation & Neural Repair.
Read More
Some proteins in cells can separate into small droplets like oil droplets in water, but faults in this process may underlie neurodegenerative diseases in the brains of older people. Now, Rutgers researchers have developed a new method to quantify protein droplets involved in these diseases, which they explain in the journal Biophysical Reports.
Read More
California’s budget for FY 2021-2022, recently signed by its governor, Gavin Newsom, includes $15 million in funding for the care and treatment of people living with ALS. It also includes $8.4 million to fund Parkinson’s disease data collection and research, according to separate news releases.
Read More
Medtronic plc announces the US Food and Drug Administration (FDA) approval and first US implants of the SenSight Directional Lead System used for Deep Brain Stimulation (DBS) therapy.
Read More
Anxiety amplifies the physical signs of Parkinson’s disease, according to people who experience both conditions, researchers suggest, in a study published in PLOS ONE.
Read More